On August 13, 2026, Encompass Health Corporation completed the private issuance of $100 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Additional Notes”). The notes were sold at a purchase price of 98.75% of the aggregate principal amount, yielding net proceeds of approximately $96.9 million after deducting discounts and offering expenses. The company utilized these net proceeds, combined with existing cash on hand, to repay a portion of the outstanding balance under its revolving credit facility. These Additional Notes are governed by the Indenture dated May 29, 2026, and rank pari passu with $500 million in Existing Notes previously issued under the same indenture. Encompass Health Corporation operates in the healthcare industry, specifically providing post-acute rehabilitation services.

Encompass Health reported second quarter 2026 results with net operating revenue increasing 9.6% to $1,597.4 million and adjusted earnings per share rising 10.7% to $1.55. The company increased its full-year 2026 guidance for adjusted EPS to a range of $6.02 to $6.25 and raised the common stock repurchase authorization by $812 million to $1 billion, bringing year-to-date buybacks to $145.8 million. Additionally, the board declared a quarterly cash dividend of $0.21 per share, payable in October 2026. Encompass Health operates as the largest owner and operator of inpatient rehabilitation hospitals in the United States.